LY377770, a novel iGlu5 kainate receptor antagonist with neuroprotective effects in global and focal cerebral ischaemia

被引:51
作者
O'Neill, MJ
Bogaert, L
Hicks, CA
Bond, A
Ward, MA
Ebinger, G
Ornstein, PL
Michotte, Y
Lodge, D
机构
[1] Eli Lilly & Co, Lilly Res Ctr Ltd, Windlesham GU20 6PH, Surrey, England
[2] Free Univ Brussels, Dept Pharmaceut Chem & Drug Anal, B-1090 Brussels, Belgium
[3] Univ Hosp Brussels, Dept Neurol, B-1090 Brussels, Belgium
[4] Lilly Corp Ctr, Indianapolis, IN 46285 USA
关键词
cerebral ischaemia; kainate receptors; iGlu5; receptor; glutamate antagonists; LY377770; neuroprotection; glutamate; microdialysis;
D O I
10.1016/S0028-3908(99)00250-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We have evaluated the neuroprotective effects of the decahydroisoquinoline LY377770, a novel iGlu5 kainate receptor antagonist, in two models of cerebral ischaemia. Global ischaemia, induced in gerbils by bilateral carotid artery occlusion (BCAO) for 5 min, produced a large increase in locomotor activity at 96 hr post-occlusion and a severe loss of CA1 cells in the hippocampus histologically at 120 hr post-occlusion. LY377770 (80 mg/kg i.p. 30 min before or 30 min after BCAO followed by 40 mg/kg i.p. administered at 3 and 6 hr after the initial dose) attenuated the ischaemia-induced hyperactivity and provided (92%) and (29%) protection in the CA1 cells respectively. This protection was greater than that seen with maximally tolerated doses of other glutamate receptor antagonists (CGS19755, CPP, MK-801, ifenprodil, eliprodil, HA-966, ACEA1021, L701,324, NBQX, LY293558, GYKI52466 and LY300164). Focal ischaemia was induced by infusing 200 pmol of endothelin-1 (Et-1) adjacent to the middle cerebral artery and LY377770 was administered at 80 mg/kg i.p. immediately, 1 or 2 hr post-occlusion followed by 40 mg/kg i.p. 3 and 6 hr after the first dose. The infarct volume, measured 72 hr later, was reduced by LY377770 when given immediately (P<0.01), at 1 hr (P<0.05) but not significantly at 2 hr post-occlusion. Reference compounds, LY293558 (20 mg/kg i.p. and then 10 mg/kg as above) and MK-801 (2.5 mg/kg i.p.), both administered immediately post-occlusion produced significant (P<0.05) but somewhat less neuroprotection. In parallel microdialysis studies, LY377770 (75 mg/kg i.p.) attenuated ischaemia-induced increases in extracellular levels of glutamate, but not of dopamine. In conclusion, these results indicated that iGlu5 kainate receptors play a central role in ischaemic brain damage following global and focal cerebral ischaemia. LY377770 is a novel, soluble, systemically active iGlu5 antagonist with efficacy in global and focal ischaemia, even when administered post-occlusion. LY377770 may therefore be useful as a neuroprotectant in man. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1575 / 1588
页数:14
相关论文
共 82 条
[31]  
Graham SH, 1996, J PHARMACOL EXP THER, V276, P1
[32]   Mitochondria and apoptosis [J].
Green, DR ;
Reed, JC .
SCIENCE, 1998, 281 (5381) :1309-1312
[33]   COMBINED POSTISCHEMIC HYPOTHERMIA AND DELAYED MK-801 TREATMENT ATTENUATES NEUROBEHAVIORAL DEFICITS ASSOCIATED WITH TRANSIENT GLOBAL-ISCHEMIA IN RATS [J].
GREEN, EJ ;
PAZOS, AJ ;
DIETRICH, WD ;
MCCABE, PM ;
SCHNEIDERMAN, N ;
LIN, B ;
BUSTO, R ;
GLOBUS, MYT ;
GINSBERG, MD .
BRAIN RESEARCH, 1995, 702 (1-2) :145-152
[34]   BRAIN TEMPERATURE AND THE NEUROPROTECTIVE ACTION OF ENADOLINE AND DIZOCILPINE IN THE GERBIL MODEL OF GLOBAL-ISCHEMIA [J].
HAYWARD, NJ ;
MCKNIGHT, AT ;
WOODRUFF, GN .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 236 (02) :247-253
[35]   Evaluation of glycine site antagonists of the NMDA receptor in global cerebral ischaemia [J].
Hicks, CA ;
Ward, MA ;
Ragumoorthy, N ;
Ambler, SJ ;
Dell, CP ;
Dobson, D ;
O'Neill, MJ .
BRAIN RESEARCH, 1999, 819 (1-2) :65-74
[36]   AMPA receptor antagonist, YM90K, reduces infarct volume in thrombotic distal middle cerebral artery occlusion in spontaneously hypertensive rats [J].
Hiroshi, Y ;
Ibayashi, S ;
Nakane, H ;
Cai, H ;
Uchimura, H ;
Fujishima, M .
BRAIN RESEARCH, 1997, 753 (01) :80-85
[37]   PROTECTION AGAINST POSTISCHEMIC BEHAVIORAL PATHOLOGY BY THE ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID (AMPA) ANTAGONIST 2,3-DIHYDROXY-6-NITRO-7-SULFAMOYL-BENZO(F)QUINOXALINE (NBQX) IN THE GERBIL [J].
JUDGE, ME ;
SHEARDOWN, MJ ;
JACOBSEN, P ;
HONORE, T .
NEUROSCIENCE LETTERS, 1991, 133 (02) :291-294
[38]   A novel AMPA receptor antagonist, YM872, reduces infarct size after middle cerebral artery occlusion in rats [J].
Kawasaki-Yatsugi, S ;
Yatsugi, S ;
Takahashi, M ;
Toya, T ;
Ichiki, C ;
Shimizu-Sasamata, M ;
Yamaguchi, T ;
Minematsu, K .
BRAIN RESEARCH, 1998, 793 (1-2) :39-46
[39]  
KOEK W, 1988, J PHARMACOL EXP THER, V245, P969
[40]   Calcium in ischemic cell death [J].
Kristián, T ;
Siesjö, BK .
STROKE, 1998, 29 (03) :705-718